KALV Stock Price Prediction 2026
KalVista Pharmaceuticals, Inc. Common Stock
AI-powered price predictions based on fundamental analysis and growth projections
- TTM Squeeze ON for 14 days - volatility compression
- Moving averages converging - equilibrium state
- MACD converging near zero line - potential energy building
- Volume showing distribution (CMF: -0.1863)
- Recent pattern: Doji - Indecision pattern
Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 70.3% upside potential.
Volume Trend: Distribution
Selling Pressure Present - Distribution pattern observed
Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $17.02 | +9.0% |
| 90 Days | $20.01 | +28.2% |
| 6 Months | $24.42 | +56.4% |
| 1 Year | $33.22 | +112.8% |
More KALV Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results
Technical Indicators
Key Fundamentals
Options Activity
Recommendation: Strong unusual activity detected. Review for potential entry.